Log in to save to my catalogue

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85d2bf813d3540bd95e68e5c58264161

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

About this item

Full title

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

Publisher

England: BioMed Central Ltd

Journal title

BMC ophthalmology, 2021-06, Vol.21 (1), p.249-249, Article 249

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

ALG3-CDG is a rare autosomal recessive disease. It is characterized by deficiency of alpha-1,3-mannosyltransferase caused by pathogenic variants in the ALG3 gene. Patients manifest with severe neurologic, cardiac, musculoskeletal and ophthalmic phenotype in combination with dysmorphic features, and almost half of them die before or during the neona...

Alternative Titles

Full title

ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_85d2bf813d3540bd95e68e5c58264161

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_85d2bf813d3540bd95e68e5c58264161

Other Identifiers

ISSN

1471-2415

E-ISSN

1471-2415

DOI

10.1186/s12886-021-02013-2

How to access this item